Age Clinical Trials in Shanghai, Shanghai Municipality
101 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 101 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled15 locationsNCT07227597
Recruiting
Phase 3
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
Not Applicable
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
Lung Cancer Stage IA
Shanghai Chest Hospital110 enrolled1 locationNCT06503744
Recruiting
Phase 2
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Limited Stage Small Cell Lung Cancer
Fudan University60 enrolled1 locationNCT06943235
Recruiting
Phase 2
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer
NSCLC Stage IINSCLC Stage III
Shanghai Pulmonary Hospital, Shanghai, China54 enrolled1 locationNCT07410975
Recruiting
Phase 1Phase 2
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IV+1 more
Forward Pharmaceuticals Co., Ltd.99 enrolled22 locationsNCT06064812
Recruiting
Phase 2
Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
Resectable Stage II-IIIa Squamous NSCLC
Fudan University116 enrolled1 locationNCT07398937
Recruiting
Phase 3
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Early-stage or Locally Advanced HER2-positive Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.740 enrolled2 locationsNCT07196774
Recruiting
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
Breast CancerAge
Fudan University120 enrolled1 locationNCT06718010
Recruiting
Phase 2
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Lung NeoplasmsThoracic NeoplasmsLung Diseases+1 more
Shanghai Pulmonary Hospital, Shanghai, China15 enrolled1 locationNCT06758700
Recruiting
Phase 2
A Study of Ivonescimab in First-Line ES-SCLC
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso180 enrolled3 locationsNCT07245446
Recruiting
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NSCLCNSCLC Stage IVNSCLC, Recurrent
Shanghai Chest Hospital500 enrolled2 locationsNCT05701787
Recruiting
Phase 2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.66 enrolled1 locationNCT06437509
Recruiting
Phase 2
A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
Mammary or Extramammary Paget's Disease
Fudan University36 enrolled1 locationNCT06561555
Recruiting
Phase 2
A Phase 2 Clinical Study of ABSK061 and ABSK043
Urothelial CarcinomaHER2-Gastric/Gastroesophageal Junction Cancer
Abbisko Therapeutics Co, Ltd202 enrolled21 locationsNCT06632262
Recruiting
Not Applicable
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Breast CancerLung CancersLiver Cancer+4 more
Guo ShiWei1,000,000 enrolled1 locationNCT06632886
Recruiting
Phase 2
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
Extensive-stage Small-cell Lung Cancer
Sichuan University61 enrolled8 locationsNCT05765825
Recruiting
Phase 2
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
Breast Cancer Stage I
Fudan University1,008 enrolled1 locationNCT05861271
Recruiting
Not Applicable
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
Stage IA Lung Cancer
Hangzhou Broncus Medical Co., Ltd.110 enrolled1 locationNCT06052098
Recruiting
Phase 2
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China96 enrolled1 locationNCT05503667